BrightPath Biotherapeutics4594 
$0.36-1.92%24h
-1.92%24h
Global rank29427
Market cap$21.62M
Change 7d-3.77%
YTD Performance-40.70%
SP500 benchmarkUnderperform
P/E-0.01
P/S576.26
Revenue$37.51K
Earnings-$10.55M
Dividend yield-
BrightPath Biotherapeutics (4594) Cash on Hand
4594 Cash on Hand in 2022: $10.88M
According to BrightPath Biotherapeutics latest financial reports the cash on hand of 4594 is $10.88M, an decrease of -33.58% to 2022. At the end of 2022 company had $16.38M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
4594 Cash on Hand History from 2019 to 2023
-
Value:-
4594 Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $10.88M | -33.58% |
| 2022 | $16.38M | -29.41% |
| 2021 | $23.20M | 8.18% |
| 2020 | $21.44M | -38.42% |
| 2019 | $34.82M | - |
View the Top Cash on Hand Companies 
